Assoc. Prof. Dr. Alberto Esteban Fernández, Hospital Universitario Severo Ochoa, Spain
Alberto Esteban Fernández, born in Valladolid on July 4, 1984, is a distinguished cardiologist and expert in heart failure, particularly in the field of myocardial diseases. With a career spanning both clinical and academic settings, Dr. Fernández has made significant contributions to research and clinical practice in cardiology. He currently holds positions as a specialist in heart failure at the Hospital Universitario Severo Ochoa and as a tutor for cardiology residents. With extensive international experience, he has collaborated with the European Society of Cardiology and several esteemed research centers. Dr. Fernández is dedicated to advancing the treatment of dilated cardiomyopathy and heart failure through innovative research and clinical care. He also plays an active role in several medical committees and ethical boards. In addition to his clinical expertise, he is a passionate educator, mentoring the next generation of cardiologists.
Professional Profile
Scopus
Orcid
Google Scholar
Suitability for the “Research for Best Researcher Award”
Alberto Esteban Fernández is an exceptional candidate for the “Research for Best Researcher Award” due to his extensive background in cardiology, particularly in heart failure, and his remarkable contributions to both clinical practice and research. He holds a Doctorate in Medicine from the University of Navarra, where his thesis on cardiac magnetic resonance imaging in ischemic heart disease showcased his expertise and commitment to advancing the field. Furthermore, his postdoctoral experience, including a research fellowship at the BHF Cardiovascular Research Centre, demonstrates his capacity to engage in high-level scientific inquiry.
His qualifications, including multiple master’s degrees, certifications in cardiology, and advanced heart failure, reflect his continuous pursuit of knowledge and professional growth. Notably, his role as a leading specialist in advanced heart failure and his leadership in cardiology departments at prominent hospitals, such as the Hospital Universitario Severo Ochoa and the Hospital Universitario de Móstoles, underline his ability to merge clinical excellence with research, creating impactful contributions to healthcare.
Education
Dr. Alberto Esteban Fernández’s academic journey is marked by a series of prestigious qualifications. He is currently pursuing a Master’s in Statistics in Health Sciences at the University of Barcelona. He earned an Expert University Degree in Family Cardiopathies from the University Francisco de Vitoria in 2021. Dr. Fernández also holds multiple advanced certifications, including the European Society of Cardiology’s HFA Certification in Heart Failure (2020), and a Doctorate in Medicine from the University of Navarra (2019), where he received the Outstanding Cum Laude distinction. His doctoral thesis focused on the use of cardiac magnetic resonance imaging in detecting myocardial ischemia. Furthermore, he completed a Master’s in Health Research Methodology at the University of Salamanca and postgraduate studies in various cardiology specialties. His academic credentials are complemented by numerous certifications in advanced cardiac care and specialized heart failure treatment, demonstrating his commitment to excellence in the medical field.
Professional Experience
Dr. Alberto Esteban Fernández has an extensive professional background, primarily in cardiology with a focus on heart failure. He is currently a Specialist at the Hospital Universitario Severo Ochoa, where he manages the heart failure unit. He has previously held key roles at the Hospital Universitario de Móstoles, where he led the heart failure unit, and at various other prestigious institutions, including the Hospital Clínico Universitario San Carlos in Madrid. Additionally, Dr. Fernández has served as a scientific editor for the Spanish Society of Cardiology’s blog and Cardioteca, contributing to the dissemination of cutting-edge research. His international experience includes fellowships at the Golden Jubilee National Hospital and the University of Glasgow, where he advanced his expertise in heart failure and transplantation. As a clinical and academic leader, Dr. Fernández is also involved in several cardiology committees and actively contributes to the medical community through teaching and mentorship.
Awards and Recognition
Dr. Alberto Esteban Fernández has received numerous accolades throughout his career, reflecting his contributions to the field of cardiology. He holds the prestigious Doctorate in Medicine from the University of Navarra, awarded with the highest distinction, Cum Laude. His work in heart failure and myocardial diseases has been recognized by the European Society of Cardiology, where he holds several certifications. Dr. Fernández was also appointed to the Heart Failure Association of the European Society of Cardiology’s committees, where he continues to influence the direction of clinical practice. He has been recognized as a leader in his field by his peers and is a key figure in Spanish cardiology. His efforts in advancing research, patient care, and medical education have earned him a reputation as one of the foremost experts in heart failure treatment and management.
Dr. Alberto Esteban Fernández is a highly skilled researcher with a focus on heart failure, myocardial diseases, and advanced cardiology techniques. His research expertise spans cardiac magnetic resonance imaging, risk stratification in heart failure, and the genetic components of cardiomyopathies. Dr. Fernández’s doctoral thesis on cardiac stress imaging for myocardial ischemia detection contributed significantly to clinical practice and research. He is adept at designing and executing clinical trials and observational studies, particularly in the context of heart failure and cardiomyopathy. Dr. Fernández has published numerous articles in high-impact journals and has presented his research at international conferences, where his work is widely recognized. His research is supported by his clinical experience, ensuring that his studies are grounded in real-world applications. Additionally, he collaborates with various research institutions and participates in international studies, contributing to the advancement of cardiology research.
Publication Top Notes
- Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation
Authors: N Calvo, N Salterain, H Arguedas, A Macias, A Esteban, …
Citation: Ep Europace 17 (10), 1533-1540
Year: 2015
- In-hospital mortality and readmissions for heart failure in Spain. A Study of Index Episodes and 30-Day and 1-year Cardiac Readmissions
Authors: PM Santos, RB Freire, AE Fernández, JLB Sobrino, CF Pérez, …
Citation: Revista Española de Cardiología (English Edition) 72 (12), 998-1004
Year: 2019
- Sacubitril/valsartan in daily clinical practice: data from a prospective registry
Authors: L Vicent, A Esteban-Fernández, M Gómez-Bueno, J De-Juan, …
Citation: Journal of Cardiovascular Pharmacology 73 (2), 118-124
Year: 2019
- Frailty and prognosis of older patients with chronic heart failure
Authors: C Jiménez-Méndez, P Díez-Villanueva, C Bonanad, C Ortiz-Cortés, …
Citation: Revista Española de Cardiología (English Edition) 75 (12), 1011-1019
Year: 2022
- Consensus document and recommendations on palliative care in heart failure of the Heart Failure and Geriatric Cardiology Working Groups of the Spanish Society of Cardiology
Authors: JMG Pinilla, P Díez-Villanueva, RB Freire, F Formiga, MC Marcos, …
Citation: Revista Española de Cardiología (English Edition) 73 (1), 69-77
Year: 2020
- Safety of sacubitril/valsartan initiated during hospitalization: data from a non‐selected cohort
Authors: JC López‐Azor, L Vicent, MJ Valero‐Masa, A Esteban‐Fernández, …
Citation: ESC Heart Failure 6 (6), 1161-1166
Year: 2019
- Sex influence on the efficacy and safety of sacubitril/valsartan
Authors: L Vicent, A Ayesta, A Esteban-Fernández, M Gómez-Bueno, J De-Juan, …
Citation: Cardiology 142 (2), 73-78
Year: 2019
- Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort
Authors: A Esteban-Fernández, P Díez-Villanueva, L Vicent, R Bover, …
Citation: Revista Espanola de Geriatria y Gerontologia 55 (2), 65-69
Year: 2020
- Mortalidad hospitalaria y reingresos por insuficiencia cardiaca en España. Un estudio de los episodios índice y los reingresos por causas cardiacas a los 30 días y al año
Authors: PM Santos, RB Freire, AE Fernández, JLB Sobrino, CF Pérez, …
Citation: Revista Española de Cardiología 72 (12), 998-1004
Year: 2019
- Clinical profile of a nonselected population treated with sacubitril/valsartan is different from PARADIGM-HF trial
Authors: L Vicent, A Esteban-Fernandez, M Gomez-Bueno, J De-Juan, …
Citation: Journal of Cardiovascular Pharmacology 72 (2), 112-116
Year: 2018